Unknown OBSERVATIONAL NCT02131610

Epigenetics Modifications in Obstructive Sleep Apnea (EPIOSA)

Epigenetics Modifications and Subclinical Atherosclerosis in Obstructive Sleep Apnea: The EPIOSA Study

Sponsor: Aragon Institute of Health Sciences

Updated 11 times since 2017 Last updated: May 4, 2014 Started: Mar 31, 2013 Primary completion: Mar 31, 2018 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02131610, this observational or N/A phase trial focuses on Sleep Apnea and Snoring and remains ongoing. Sponsored by Aragon Institute of Health Sciences, it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 6 earlier versions

Apr 2019 — Nov 2020 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Apr 2019 [monthly]

Recruiting
May 2018 — Jun 2018 [monthly]

Recruiting
Apr 2018 — May 2018 [monthly]

Recruiting

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aragon Institute of Health Sciences
Hospital Miguel Servet
Instituto Aragones de Ciencias de la Salud

Data source: Aragon Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zaragoza, Spain